Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Camille Danne, a postdoctoral researcher at the Kennedy Institute, has been awarded a prestigious 2-year Marie Skłodowska-Curie Fellowship. The fellowship will support Camille in the next stage of her career as she joins Professor Harry Sokol’s laboratory at the INRA Research Center at Jouy-en-Josas, France.

Working with Prof Fiona Powrie, Camille’s research has examined how Helicobacter hepaticus  - a microbe that commonly inhabits the gut – promotes healthy immune responses in the intestine.

Camille will continue to apply her expertise in the microbiome in her new position, where she will explore how genetic mutations linked to inflammatory bowel disease disrupt populations of beneficial gut microbes leading to inflammation.

The Marie Skłodowska-Curie Fellowship programme provides support to experienced postdoctoral researchers who wish to move to or within Europe to enhance their career development.

We wish Camille all the best in her new position.

 

 

Similar stories

Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park

Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.